Male hypogonadism: Testosterone therapy is not dangerous
The EAU Guidelines Office will provide a state-of-the-art update on male hypogonadism and testosterone replacement therapy. This recording will be of great educational value for urologists as internationally-known experts will focus on the controversial and challenging areas of this rapidly evolving field, and provide you with vital insights.
Testosterone replacement therapy is indicated in a variety of clinical conditions and has shown to improve the quality of life in patients with hypogonadism. In addition, the therapy may also have other beneficial effects on long-term cardiovascular health. However, patients receiving testosterone replacement therapy should be fully counselled on the risks and advantages of the treatment.
The recording will discuss the current EAU Guidelines and the evidence base for treating men with hypogonadism, as well as highlight controversial areas. The expert discussion will also provide an up-to-date guidance on the safety profile of testosterone replacement therapy focusing on the potential long-term cardiovascular effects and the potential risks on prostate health. The recording will also highlight and discuss the effects of testosterone on bone metabolism.
Speakers:
Dr. G. Corona (IT)
Dr. P. Capogrosso (IT)
Prof. A. Salonia (IT)
Prof. S. Minhas (GB)
Prof. T.H. Jones (GB)
This e-course is brought to you in collaboration with the EAU Guidelines office.
🌟 Important info:
The recording of this webinar is not EU-ACME accredited.
Missed the live session? Earn 1 CME point by completing our online e-course at: [ Ссылка ]
Don't miss this opportunity! 🎓💡
